Vivos Therapeutics, Inc. ( (VVOS) ) has released its Q2 earnings. Here is a breakdown of the information Vivos Therapeutics, Inc. presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vivos Therapeutics, Inc. is a medical technology company specializing in proprietary oral appliances and therapeutic treatments for sleep disorders, particularly obstructive sleep apnea (OSA). The company operates in the healthcare sector and is known for its innovative, non-surgical solutions for maxillofacial abnormalities linked to breathing and sleep issues.
In its latest earnings report for the quarter ending June 30, 2025, Vivos Therapeutics highlighted a strategic shift in its business model, focusing on acquisitions and alliances with sleep centers to drive revenue. This pivot aims to reduce reliance on dentist-driven sales and capitalize on direct patient interactions through sleep disorder centers.
Financially, the company reported a decrease in total revenue to $3.82 million for the quarter, down from $4.05 million the previous year. The net loss widened to $5.01 million compared to a loss of $1.93 million in the same quarter last year. This increase in losses is attributed to higher operating expenses, primarily due to the acquisition of The Sleep Center of Nevada and the associated costs.
Despite the current financial challenges, Vivos Therapeutics is optimistic about its new business strategy. The acquisition of The Sleep Center of Nevada is expected to enhance its market presence and provide new revenue streams. The company is actively exploring further acquisitions and partnerships to expand its reach in the sleep disorder treatment market.
Looking ahead, Vivos Therapeutics’ management remains focused on integrating its recent acquisition and refining its sales, marketing, and distribution model. The company aims to leverage its innovative products and strategic alliances to achieve sustainable growth and improve financial performance in the coming quarters.